Found: 10
Select item for more details and to access through your institution.
A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance.
- Published in:
- Health & Quality of Life Outcomes, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12955-024-02239-w
- By:
- Publication type:
- Article
Viral load kinetics and the clinical consequences of cytomegalovirus in kidney transplantation.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1302627
- By:
- Publication type:
- Article
Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231646
- By:
- Publication type:
- Article
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.
- Published in:
- Antiviral Therapy, 2023, v. 28, n. 5, p. 1, doi. 10.1177/13596535231195431
- By:
- Publication type:
- Article
Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.
- Published in:
- Health & Quality of Life Outcomes, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7525-11-167
- By:
- Publication type:
- Article
Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior treatment: Exploratory analysis of the Phase 3 SOLSTICE trial
- Published in:
- Transplant Infectious Disease, 2023, v. 25, n. 3, p. 1, doi. 10.1111/tid.14064
- By:
- Publication type:
- Article
Coinfection rates and clinical outcome data for cytomegalovirus and Epstein‐Barr virus in post‐transplant patients: A systematic review of the literature.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 6, p. 1, doi. 10.1111/tid.13396
- By:
- Publication type:
- Article
Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0180261
- By:
- Publication type:
- Article